JAZZ
What one share of Jazz Pharmaceuticals holds
Pharmaceutical Preparations
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease – often with limited or no therapeutic options.
Jazz Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $71.53 |
|---|---|
| Profit | $14.62 |
| Capex (buildings and equipment) | $1.08 |
| Free cash flow | $24.74 |
| Cash and investments | $24.95 |
| Debt | $67.03 |
| Book value | $73.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $4.28 | −$0.23 | $0.00 | −$0.53 | — | −$2.43 |
| 2010 | $4.41 | $0.83 | $0.02 | $1.48 | — | $0.76 |
| 2011 | $5.82 | $2.67 | $0.03 | $3.21 | — | $4.54 |
| 2012 | $9.73 | $4.79 | $0.10 | $4.05 | — | $19.33 |
| 2013 | $14.17 | $3.51 | $0.16 | $4.52 | — | $22.39 |
| 2014 | $18.73 | $0.93 | $0.58 | $5.93 | — | $22.61 |
| 2015 | $21.02 | $5.23 | $0.57 | $7.87 | — | $27.83 |
| 2016 | $24.05 | $6.41 | $0.16 | $9.42 | — | $31.38 |
| 2017 | $26.40 | $7.96 | $0.47 | $10.83 | — | $46.06 |
| 2018 | $30.89 | $7.30 | $0.33 | $12.72 | — | $47.79 |
| 2019 | $37.56 | $9.09 | $0.70 | $12.79 | — | $55.41 |
| 2020 | $41.82 | $4.22 | $0.27 | $15.65 | — | $65.15 |
| 2021 | $51.84 | −$5.52 | $0.46 | $12.58 | — | $64.34 |
| 2022 | $58.51 | −$3.58 | $0.46 | $19.87 | — | $48.81 |
| 2023 | $53.20 | $6.10 | $0.33 | $14.82 | — | $60.03 |
| 2024 | $61.64 | $8.65 | $0.58 | $20.57 | — | $67.52 |
| 2025 | $69.98 | −$5.84 | $0.96 | $21.27 | — | $70.30 |